ABL Diagnostics Boosts FY2025 Dividend Proposal
ABL Diagnostics, a company specialised in molecular diagnostics for infectious diseases, announces that its Board of Directors, at its meeting held on April 30, 2026, has decided to propose to the Combined General Meeting to be held on June 30, 2026, the distribution of a dividend of €0.11 per share for the financial year ended […]
Blend Labs Partners with Haveli Investments securing USD 150Mln investment
Blend Labs, Inc., a leading provider of cloud banking services,and Haveli Investments (“Haveli”), a technology-focused private equity firm, today announced a $150 million investment in the Company by Haveli Investments in the form of convertible preferred stock with a zero percent coupon. Blend will use approximately $145 million of the proceeds to repay all amounts […]
